Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Liability and Injury Evaluations: Understanding the Two Types of Recommendation Models
Third party bodily injury teams use a number of different approaches and tools to settle claims, but they do share a similar set of goals—settling claims efficiently and accurately.
The 5 Essentials Every Third Party Claim Workflow Needs
Recent third party claim costs have risen significantly— from the start of 2018 through the end of 2020, average charge per claimant in Mitchell’s aggregated industry data has increased 53% for third party claims.
Workers’ Comp Data: Restaurant and Hospitality, Educational Services Industries Still Experiencing Low Volume of Workers’ Comp Claims
Data analysis by Aarthi Thiruvengadam. As the COVID-19 pandemic goes on, the workers’ compensation industry is still continuing to manage changing claim patterns and trends.
5 Steps to Prepare for a Successful Post-COVID Future
In the span of just about a year and a half, the auto casualty and workers’ comp insurance industry has seen more transformation than perhaps in the past decade. From increased technology implementation to changes in the makeup and frequency of claims, the industry appears much different than it did at the start of 2020.
Addressing Physician Dispensed Medications with Price Opportunist Drug Strategies
Does your pharmacy program have strategies in place to manage physician dispensed medications, such as dermatologicals and other high-cost products?
What Do We Know About Post-COVID Conditions?
Post-COVID conditions is the CDC term used to describe health issues that persist more than four weeks after a person is first infected with the virus that causes COVID-19. The exact cause of and risk factors for developing post-COVID conditions are not yet fully understood.